journal article Apr 09, 2024

Comparative Safety of Istradefylline Among Parkinson’s Disease Adjunctive Therapies: A Systematic Review and Meta-analysis of Randomized Controlled Studies (P5-3.017)

View at Publisher Save 10.1212/wnl.0000000000205249
Topics

No keywords indexed for this article. Browse by subject →

Metrics
1
Citations
0
References
Details
Published
Apr 09, 2024
Vol/Issue
102(7_supplement_1)
Cite This Article
Yasar Torres-Yaghi, Joyce Qian, Hannah Cummings, et al. (2024). Comparative Safety of Istradefylline Among Parkinson’s Disease Adjunctive Therapies: A Systematic Review and Meta-analysis of Randomized Controlled Studies (P5-3.017). Neurology, 102(7_supplement_1). https://doi.org/10.1212/wnl.0000000000205249
Related

You May Also Like

Clinical diagnosis of Alzheimer's disease

Guy McKhann, David Drachman · 1984

27,913 citations

Rating neurologic impairment in multiple sclerosis

John F. Kurtzke · 1983

12,541 citations

Parkinsonism

Margaret M. Hoehn, Melvin D. Yahr · 1967

9,581 citations

The Clinical Dementia Rating (CDR)

· 1993

7,899 citations

The Neuropsychiatric Inventory

J. L. Cummings, M. Mega · 1994

6,206 citations